UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Incor ...

Milestone Scientific Inc. (NYSE:MLSS) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants David Waldman – Investor Relations Arjan Haverhals – Chief Executive Officer Peter Milligan – Chief Financial Officer Conference Call Participants Anthony Vendetti – Maxim Group Operator Good morning, everyone. And welcome to Milestone Scientific’s First Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions] Please note, this conference is being recorded. I ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Inco ...

财务数据和关键指标变化 - 2022年全年总收入为8.8百万美元,较2021年同期的10.3百万美元下降了15% [5] - 牙科业务收入下降1.4百万美元,其中中国市场下降1.4百万美元,美国市场下降278,000美元 [5] - 医疗业务收入从2021年的152,000美元下降至2022年的53,000美元 [5] - 毛利率从2021年的61%下降至2022年的56% [5] - 全年经营亏损为8.8百万美元,较2021年的7.4百万美元增加 [5] - 2022年12月31日,公司现金及现金等价物为8.7百万美元,流动资产为13.7百万美元,流动资金为10百万美元 [5] 各条业务线数据和关键指标变化 牙科业务 - 公司终止了与之前的美国分销商的协议,转而采用直销模式,这导致2022年第四季度销售额下降 [4] - 但公司相信新的直销模式将提供更好的客户关系和更高的毛利率,未来几个季度内可能会带来更高的销售额和利润 [4] - 公司在国际市场持续实现增长,特别是在巴西和欧洲市场 [4] 医疗业务 - 公司获得了CompuFlo硬膜外系统在胸椎区域使用的FDA 510(k)批准,这大大扩展了可应用的适应症范围 [3][6] - 公司还获得了临时的CPT编码,有助于推动私人疼痛管理诊所的采用 [3][6] - 公司正在积极推进联邦供应系统(FSS)的批准,这将有助于进入政府市场 [6] 各个市场数据和关键指标变化 - 公司正在加强在私人疼痛管理诊所的渗透,这些诊所的决策周期更短 [3][6] - 公司正在拓展国际分销网络,包括在希腊和美国中西部地区新增分销商 [3] - 公司正在加强对患者的直接营销,以提高牙科业务的销售 [19] 公司战略和发展方向及行业竞争 - 公司正在努力将CompuFlo硬膜外系统确立为硬膜外麻醉的新标准,提供更安全有效的疼痛缓解 [3][6] - 公司正在优化牙科业务的销售策略,包括建立直销门户网站以及拓展国际分销渠道 [4] - 公司正在审慎管理费用,同时投资于销售、营销和新产品开发 [4][5] 管理层对经营环境和未来前景的评论 - 管理层对公司的发展前景持乐观态度,认为公司已经具备了更多的工具和资源来推动业务增长 [11][12][13][14] - 管理层表示,公司正在执行既定的战略,并将继续努力提高运营效率和财务状况,为股东创造价值 [6][32] 问答环节重要的提问和回答 问题1 **Anthony Vendetti 提问** 询问公司从之前的分销商转向直销模式的情况,以及对2023年医疗业务发展的预期 [8][11][12][13] **Arjan Haverhals 回答** - 公司转向直销模式是为了提高毛利率,尽管短期内可能会影响销售,但长期来看将带来更高的收入和利润 [8][9][10] - 公司获得了CompuFlo在胸椎区域的FDA批准以及临时CPT编码,这大大拓展了可应用的适应症和潜在市场,有助于加快在私人疼痛管理诊所的渗透 [11][12][13] - 公司正在积极推进联邦供应系统的批准,以开拓政府市场,并将继续执行既定战略,努力提高运营效率和财务状况 [6][13][32] 问题2 **John Korb 提问** 询问公司是否还在等待其他FDA批准,以及对2023年业务发展的预期 [16][17][19][20][22] **Arjan Haverhals 回答** - 公司目前主要集中于现有产品组合和技术,暂无其他FDA申请 [17] - 公司正在加强对患者的直接营销,以提高牙科业务的销售 [19] - 公司对未来发展持乐观态度,但不会做出具体的时间承诺,而是专注于执行既定战略 [22] 问题3 **Mike Pfeffer 提问** 询问公司未来现金消耗的预期,以及CPT编码和联邦供应系统批准的进展情况 [24][25][27] **Arjan Haverhals 回答** - 公司预计2023年现金消耗将低于去年水平,直销模式有助于改善现金流管理 [24] - 公司正在等待医疗保险公司对使用CPT编码的反馈,并将继续推动更多诊所提交理赔 [25][26] - 公司已获得SAM批准,正在推进联邦供应系统的批准,预计在未来几个季度内有进展 [27]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction ...

Milestone Scientific Inc. (NYSE:MLSS) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day ladies and gentlemen and welcome to the Milestone Scientific???s Third Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after ...

Milestone Scientific Inc. (NYSE:MLSS) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Milestone Scientific Second Quarter 2022 Business Update Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would ...

Milestone Scientific Inc. (NYSE:MLSS) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific First Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode, and the floor will be opened for questions an ...

Milestone Scientific Inc. (NYSE:MLSS) Q4 2021 Results Conference Call April 1, 2022 8:30 AM ET Company Participants Natalya Rudman - Crescendo Communications Arjan Haverhals - Chief Executive Officer Keisha Harcum - Controller Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific Fiscal 2021 Year End Business Update Call. At this time, all participants have been placed in a listen-only mode and we will open the floor ...

Milestone Scientific Inc. (NYSE:MLSS) Q3 2021 Earnings Conference Call November 15, 2021 11:00 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Keisha Harcum - Controller of Milestone Scientific Conference Call Participants Anthony Vendetti - Maxim Group James Terwilliger - Northland Securities Howard Yeager - Newbridge Bill Stein - Celadon Financial Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific Third Quarter 2021 ...